Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Основные терапевтические подходы к лечению цереброваскулярной патологии - Справочник поликлинического врача №11 (2014)
Основные терапевтические подходы к лечению цереброваскулярной патологии
Х.Я.Умарова, А.В.Чугунов. Основные терапевтические подходы к лечению цереброваскулярной патологии. Справочник поликлинического врача. 2014; 11: 12–16.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М., 2001.
2. Гусев Е.И., Камчатнов П.Р. Пластичность головного мозга в норме и патологии. Журн. неврологии и психиатрии. 2004; 2: 73–80.
3. Mir C, Clotet J, Aledo R. CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J Mol Neurosci 2003; 20: 53–60.
4. Wurtman R, Regan M, Ulus I, Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol 2000; 60: 989–95.
5. Rao A, Hatcher J. Does CDP-choline modulate phospholipase activities after transient forebrain ischemia. Brain Res 2001; 893: 268–72.
6. Hurtado O, Moro MA, Cardenas A et al. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis 2005; 18: 336–45.
7. Fiedorowicz М, Makarewicz D, Stańczak-Mrozek К, Grieb Р. CDP-choline (citicoline) attenuates brain damage in a rat model of birth asphyxia. Acta Neurobiol Exp 2008; 68: 389–97.
8. Schuettauf F, Rejdak R, Thaler S et al. Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp Eye Res 2006; 83: 1128–34.
9. Garcia-Bonilla L, Giralt D, Bustamante A et al. Citicoline in pre-clinical animal models of stroke: A meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial. J Neurochem 2012. Doi: 10.1111/j.1471-4159.2012.07891.x.
10. Lee H-J, Kang JS, Kim YI. Citicoline Protects Against Cognitive Impairment in a Rat Model of Chronic Cerebral Hypoperfusion. J Clin Neurol 2009; 5: 33–8.
11. Secades J, Lorenzo J. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006; 28 (Suppl. B): 1–56.
12. Zafonte R, Friedewald W, Lee S et al. The citicoline brain injury treatment (COBRIT) trial: design and methods. J Neurotrauma 2009; 26 (12): 2207–16.
13. Dávalos А, Castillo А, Álvarez-Sabín М. Oral Citicoline in acute ischemic stroke. An individual patient data pooling Analysis of clinical trials. Stroke 2002; 33: 2850–7.
14. Clark W. Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother 2009; 10 (5): 839–46.
15. Dávalos А, Álvarez-Sabín J, Castillo J et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012; 380 (9839): 349–57.
16. Мартынов М.Ю., Бойко А.Н., Камчатнов П.Р. и др. Нейропротективная терапия цитиколином. Журн. неврологии и психиатрии. Инсульт. 2012; 112 (3): 16–21.
17. Bruce S, Werner K, Preston B, Baker L. Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage. Int J Food Sci Nutr 2014; 6: 1–5.
18. Putignano S, Gareri P, Castagna A et al. Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome. Clinical Interventions in Aging 2012; 7: 113–8.
19. Rejdak R, Toczołowski J, Solski J et al. Citicoline treatment increases retinal dopamine content in rabbits. Ophtalmic Res 2002; 34: 146–9.
20. Álvarez-Sabín J, Roman G. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke 2011; 42 (Suppl. 1): S40–S43.
21. Hurtado O, Lizasoain I, Moro M. Neuroprotection and recovery: recent data at the bench on citicoline. Stroke 2011; 42 (Suppl. 1): S33–S35.
22. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP choline) for cognitive and behavioral disturbances associated with chronic cerebral disorders in the elderly (Cochrane Methodology Review). In: The Cochrane Library, Issue ft., 2003.
23. Álvarez-Sabín J, Ortega G, Jacas C et al. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis 2013; 35 (2): 146–54.
24. Zafonte R, Bagiella E, Ansel B et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA 2012; 308 (19): 1993–2000.
25. Ottobelli L, Manni G, Centofanti M et al. Citicoline oral solution in glaucoma: is there a role in slowing disease progression? Ophthalmologica 2013; 229: 219–26.
2. Гусев Е.И., Камчатнов П.Р. Пластичность головного мозга в норме и патологии. Журн. неврологии и психиатрии. 2004; 2: 73–80.
3. Mir C, Clotet J, Aledo R. CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J Mol Neurosci 2003; 20: 53–60.
4. Wurtman R, Regan M, Ulus I, Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol 2000; 60: 989–95.
5. Rao A, Hatcher J. Does CDP-choline modulate phospholipase activities after transient forebrain ischemia. Brain Res 2001; 893: 268–72.
6. Hurtado O, Moro MA, Cardenas A et al. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis 2005; 18: 336–45.
7. Fiedorowicz М, Makarewicz D, Stańczak-Mrozek К, Grieb Р. CDP-choline (citicoline) attenuates brain damage in a rat model of birth asphyxia. Acta Neurobiol Exp 2008; 68: 389–97.
8. Schuettauf F, Rejdak R, Thaler S et al. Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp Eye Res 2006; 83: 1128–34.
9. Garcia-Bonilla L, Giralt D, Bustamante A et al. Citicoline in pre-clinical animal models of stroke: A meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial. J Neurochem 2012. Doi: 10.1111/j.1471-4159.2012.07891.x.
10. Lee H-J, Kang JS, Kim YI. Citicoline Protects Against Cognitive Impairment in a Rat Model of Chronic Cerebral Hypoperfusion. J Clin Neurol 2009; 5: 33–8.
11. Secades J, Lorenzo J. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006; 28 (Suppl. B): 1–56.
12. Zafonte R, Friedewald W, Lee S et al. The citicoline brain injury treatment (COBRIT) trial: design and methods. J Neurotrauma 2009; 26 (12): 2207–16.
13. Dávalos А, Castillo А, Álvarez-Sabín М. Oral Citicoline in acute ischemic stroke. An individual patient data pooling Analysis of clinical trials. Stroke 2002; 33: 2850–7.
14. Clark W. Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother 2009; 10 (5): 839–46.
15. Dávalos А, Álvarez-Sabín J, Castillo J et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012; 380 (9839): 349–57.
16. Мартынов М.Ю., Бойко А.Н., Камчатнов П.Р. и др. Нейропротективная терапия цитиколином. Журн. неврологии и психиатрии. Инсульт. 2012; 112 (3): 16–21.
17. Bruce S, Werner K, Preston B, Baker L. Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage. Int J Food Sci Nutr 2014; 6: 1–5.
18. Putignano S, Gareri P, Castagna A et al. Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome. Clinical Interventions in Aging 2012; 7: 113–8.
19. Rejdak R, Toczołowski J, Solski J et al. Citicoline treatment increases retinal dopamine content in rabbits. Ophtalmic Res 2002; 34: 146–9.
20. Álvarez-Sabín J, Roman G. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke 2011; 42 (Suppl. 1): S40–S43.
21. Hurtado O, Lizasoain I, Moro M. Neuroprotection and recovery: recent data at the bench on citicoline. Stroke 2011; 42 (Suppl. 1): S33–S35.
22. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP choline) for cognitive and behavioral disturbances associated with chronic cerebral disorders in the elderly (Cochrane Methodology Review). In: The Cochrane Library, Issue ft., 2003.
23. Álvarez-Sabín J, Ortega G, Jacas C et al. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis 2013; 35 (2): 146–54.
24. Zafonte R, Bagiella E, Ansel B et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA 2012; 308 (19): 1993–2000.
25. Ottobelli L, Manni G, Centofanti M et al. Citicoline oral solution in glaucoma: is there a role in slowing disease progression? Ophthalmologica 2013; 229: 219–26.
Авторы
Х.Я.Умарова1, А.В.Чугунов2
1 ФГБОУ ВПО Чеченский государственный университет, Грозный;
2 ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва
1 ФГБОУ ВПО Чеченский государственный университет, Грозный;
2 ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.